## AAL: American Airlines Group Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 2.6% below STRENGTH zone (4.0-10.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($14.85)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. American Airlines stock faces Monday test after Caribbean flight cancellations; AAL last up 1%**
- Source: ts2.tech | 20260104T054800 | Somewhat-Bearish | Relevance: 100%
- American Airlines shares closed up about 1% on Friday, but face a test on Monday after widespread Caribbean flight cancellations due to FAA airspace restrictions over the weekend. Investors will closely watch for disruption costs, operational fallout, and any ripple effects from geopolitical events or oil price volatility. The airline has issued travel waivers for affected passengers, and the market will also factor in upcoming economic data like the ISM manufacturing report and U.S. employment figures.

**2. Assessing American Airlines Group (AAL) Valuation After Earnings Beat And Upgraded Guidance**
- Source: Simply Wall Street | 20260105T050904 | Somewhat-Bearish | Relevance: 100%
- American Airlines Group (AAL) recently exceeded EPS estimates and upgraded guidance, leading to a 26.4% stock climb. Despite this, one narrative suggests AAL is 45.9% overvalued due to its balance sheet, while another analysis indicates it trades at a P/E of 17x compared to a fair ratio of 24.5x, implying potential undervaluation. The article highlights the contrasting views on AAL's valuation, considering both its financial health and market multiples.

**3. American resumes Eastern Caribbean flying | Adds 5,000 seats and largest aircraft**
- Source: American Airlines Newsroom | 20260104T150916 | Somewhat-Bullish | Relevance: 100%
- American Airlines has resumed flights to the Eastern Caribbean after an airspace closure, adding nearly 5,000 seats and deploying larger aircraft, including a Boeing 777-300, to accommodate affected customers. The airline has also added numerous extra flights to various destinations in the region for January 4th and 5th. This effort aims to help passengers get to and from the region as quickly as possible.

**4. American Airlines Group Inc. $AAL Stake Cut by U S Global Investors Inc.**
- Source: MarketBeat | 20260104T120916 | Neutral | Relevance: 100%
- U S Global Investors Inc. significantly cut its stake in American Airlines Group Inc. by 16.0% during Q3, selling over 1.2 million shares, though it remains a substantial holding at 8.2% of their portfolio. American Airlines (NASDAQ:AAL) reported stronger-than-expected Q3 earnings and issued positive guidance for Q4 2025 and FY2025. Analysts currently hold a "Hold" consensus rating for AAL, with an average price target of $16.46.

**5. American Airlines resumes flights to the Caribbean after FAA reopens airspace**
- Source: KVUE | 20260104T195716 | Somewhat-Bullish | Relevance: 100%
- American Airlines announced it would resume flights to the Caribbean and add nearly 5,000 additional seats after the FAA reopened the eastern Caribbean airspace. Commercial flights were grounded on Saturday, January 3, due to a "security situation related to military activity" in Venezuela, which involved a U.S. military operation capturing Venezuelan President NicolÃ¡s Maduro. American Airlines plans to add extra flights and use larger aircraft on January 4 and 5 to help travelers affected by the closure.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | Wells Fargo | $17 | $0 | 0% |
| 2025-12-12 | UBS | $20 | $14 | +43% |
| 2025-12-09 | BMO Capital | $17 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | Wells Fargo | init | Equal-Weight |
| 2025-12-12 | UBS | up | Buy |
| 2025-12-09 | BMO Capital | init | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 5 ($1.92M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.4% (-0.4%)
- Blackrock Inc.: 8.5% (-2.5%)
- Primecap Management : 7.5% (-7.2%)
- Shaw D.E. & Co., Inc: 4.1% (+961.5%)
- UBS Group AG: 3.8% (+0.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +3.2% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 0.47 indicates undervaluation relative to growth. Forward P/E 8.5x attractive for 198% earnings growth. Analyst sentiment positive (1 raises, avg +43%, $18 target (+15%)). Insider selling cluster ($1.9M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $10.4B |
| Beta | 1.23 |
| 52W Range | $8.50 - $19.10 |
| Short Interest | 7.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.47 |
| Forward P/E | 8.5 |
| Current P/E | 25.4 |
| YoY Growth | 198.1% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -0.6% to 2.6% (+3.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.4pp (needs >4.0% for momentum thesis). MRS_5 at 2.5% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +MUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.61% (CS: 70) | Neutral |
| RSI_14 | 62.3 | Neutral |
| MACD Histogram | -0.08 | Bearish |
| vs SMA20 | 1.028x | Above |
| vs SMA50 | 1.122x | Above |
| vs SMA200 | 1.299x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $15.83
- **Stop Loss:** $14.85 (6.2% risk)
- **Target:** $16.81 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1408
- **Position Value:** $22,288.64
- **Portfolio %:** 22.29%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-01-22 (Est: $0.48)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.28 | $-0.17 | +38.2% |
| 2025Q2 | $0.77 | $0.95 | +22.7% |
| 2025Q1 | $-0.67 | $-0.59 | +11.7% |
| 2024Q4 | $0.66 | $0.86 | +30.1% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*